What now for GP consortia?
July 13, 2011Sales and Marketing GP consortia, NHS reforms
David Cameron unveiled major changes to the direction of the health reforms on 8 June – and in doing so, …
Sanofi eyes phase III move for sarilumab in rheumatoid arthritis
July 13, 2011Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab
Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …
Pharma regulators consult on drug development initiatives
July 13, 2011Research and Development Companion Diagnostics, EMA, FDA, Pharmacogenomics, biomarkers, research and development news
Pharma regulators in the US and Europe have put out separate consultations on issues affecting how medicines are developed. The …
Amgen collaborates on cancer antibody research
July 13, 2011Research and Development Amgen, Cancer, TGF-beta monoclonal antibody, research and development news
Amgen has teamed up with German biotech Micromet to develop tumour-destroying antibodies in a two-year deal that could net Micromet …
Clavis Pharma appoints Nicholas Adams
July 13, 2011Research and Development appointment, research and development
Norwegian cancer drug development company Clavis Pharma has appointed Nicholas Adams as chief business officer. He has more than 23 …
Kantar Health Launches Global Health and Wellness Quarterly Update
July 12, 2011Sales and Marketing Kantar Health, depression, emerging markets, information, newsletter, work productivity
The inaugural issue of Kantar Health’s Global Health and Wellness Update is now available. This is a quarterly newsletter sharing …
EMA widens safety review of Sanofi’s Multaq
July 12, 2011Sales and Marketing Multaq, Sanofi
European regulators are to extend their assessment of the risks associated with Sanofi’s atrial fibrillation (AF) medicine Multaq to take …
Cellectis appoints Dr Andrew Scharenberg
July 12, 2011Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development
Paris-based genome engineering specialist Cellectis Therapeutics has appointed Dr Andrew Scharenberg as chief scientific officer. He is an attending physician …
EMA plans adverse event reports for the public
July 12, 2011Research and Development, Sales and Marketing EMA, adverse events, patient information
The EMA will start producing monthly adverse event reports for the public as part of its plans to open up …
New $50m plant unveiled by Kyowa Hakko Kirin
July 12, 2011Manufacturing and Production Kyowa Hakko Kirin, pharma manufacturing news
Japan’s Kyowa Hakko Kirin is to build a new manufacturing unit for oral formulations at its main production facility in …
OctoPlus wins Danish development, manufacturing contract
July 12, 2011Manufacturing and Production OctoPlus, pharma manufacturing news
Dutch drug delivery specialist OctoPlus has been awarded a contract with an unidentified Danish drugmaker based on its microsphere technology. …
Lonza buys Arch Chemicals for $1.2 billion
July 12, 2011Manufacturing and Production Lonza, pharma manufacturing news
Swiss fine chemical and contract manufacturing company Lonza has agreed to buy Arch Chemicals of the USA for $1.2 billion …
Takeda forced to withdraw Actos in France
July 11, 2011Sales and Marketing Actos, Competact, Takeda, diabetes
Takeda has officially taken its diabetes drug Actos off the market in France at the request of the country’s medicines …
Cadila plant in India gets FDA warning
July 11, 2011Manufacturing and Production Cadila, FDA warning letter, pharma manufacturing news
Indian drugmaker Cadila Healthcare has been taken to task by the US FDA for quality violations at a new sterile …
Pfizer’s ageing blockbuster Lipitor wins $770m paediatric boost
July 11, 2011Sales and Marketing Lipitor, Pfizer, paediatric trials
Pfizer has been given more time to sell its anti-cholesterol treatment Lipitor exclusively in Europe as a quid pro quo …
Sanofi sells dermatology unit for $425m
July 11, 2011Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi, Valeant, dermatology
Sanofi has sold its Canadian dermatology unit Dermik for $425 million in order to concentrate on key growth areas like …
Lousia Roberts and Ralph Torbay join Idea Pharma
July 11, 2011Sales and Marketing appointment, sales and marketing
Idea Pharma has two new additions to its team, appointing Louisa Roberts and Ralph Torbay. Louise joins the phase II …
Novartis’ Votubia reduces benign brain tumours in SEGA patients
July 11, 2011Research and Development Novartis, SEGA, Votubia, everolimus
Novartis’ novel cancer drug Votubia has reduced the size of SEGA brain tumours in a late-stage trial. Votubia (or everolimus …
Kantar Health Names Werner Guminski CEO, Commercial Strategy
July 8, 2011Business Services, Research and Development Kantar Health, commercial strategy
Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
